Profile data is unavailable for this security.
About the company
Eve & Co Incorporated is a Canada-based company, which holds cultivation and processing licenses for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil. It is a licensed producer of medicinal marijuana. It also provides educational information and online support for its customers and first-time buyers. Its products include The Boss Bath Bomb, The Dreamer Bath Bomb, The Lover Bath Bomb, The Optimist CBD Bath Bomb, Indica Blend, Sativa Blend, The Boss, The Confidant, The Creator, The Lover, The Adventurer, The Advocate, and The Free Spirit. Its wholly owned subsidiary is Natural MedCo Ltd. The Boss Bath Bomb has an invigorating blend of sweet orange, lemon, and grapefruit essential oils that come together to enhance and lift mood, reduce stress, and stimulate circulation. The Dreamer Bath Bomb has calming lavender and chamomile essential oils that help to reduce stress and anxiety and promote calmness.
- Revenue in CAD (TTM)7.77m
- Net income in CAD-5.92m
- Incorporated2014
- Employees--
- LocationEve & Co Inc2941 Napperton DriveSTRATHROY N7G3H8CanadaCAN
- Websitehttps://www.evecannabis.ca/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aequus Pharmaceuticals Inc | 278.21k | -2.86m | 1.99m | 12.00 | -- | -- | -- | 7.15 | -0.0216 | -0.0216 | 0.0021 | -0.0423 | 0.2937 | 1.34 | 4.26 | -- | -302.43 | -97.96 | -- | -293.31 | 53.31 | -- | -1,029.67 | -141.53 | 0.0431 | -13.68 | 10.65 | -- | -81.53 | -28.97 | 7.64 | -- | -- | -- |
Intellipharmaceutics International Inc | 1.23m | -4.30m | 2.64m | 33.00 | -- | -- | -- | 2.15 | -0.13 | -0.13 | 0.0371 | -0.5275 | 0.6027 | -- | 3.37 | -- | -211.39 | -132.15 | -- | -- | -88.96 | -- | -350.72 | -499.37 | -- | -19.36 | -- | -- | -- | -58.75 | 43.78 | -- | -- | -- |
Radient Technologies Inc | 3.15m | -11.30m | 2.68m | 33.00 | -- | -- | -- | 0.8527 | -0.0216 | -0.0216 | 0.006 | -0.0278 | 0.1108 | 1.56 | 6.00 | -- | -39.76 | -67.36 | -- | -118.27 | -3.91 | 1.66 | -359.00 | -534.11 | 0.0251 | -3.58 | -- | -- | 45.49 | 65.30 | 69.41 | -- | 200.33 | -- |
Manitex Capital Inc. | 0.00 | 676.04k | 2.83m | -- | 4.22 | 0.335 | 5.13 | -- | 0.0534 | 0.0534 | 0.00 | 0.6716 | 0.00 | -- | -- | -- | 7.45 | -10.84 | 8.10 | -11.51 | -- | -- | -- | -- | -- | -- | 0.0392 | -- | -- | -- | 103.54 | 17.10 | -- | -- |
Eve & Co Inc | 7.77m | -5.92m | 3.74m | -- | -- | -- | -- | 0.4812 | -0.2055 | -0.2055 | 0.2698 | 0.733 | 0.1519 | 0.7493 | 8.73 | -- | -11.58 | -- | -24.24 | -- | -3.10 | -- | -76.22 | -- | 0.062 | -5.05 | 0.4892 | -- | 2.94 | -- | -71.97 | -- | -- | -- |